Adverum Biotechnologies Late Thursday Reported Q3 EPS $(0.25) Beats $(0.26) Estimate, Sales $250K Beat $180K Estimate

Adverum Biotechnologies (NASDAQ:ADVM) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.26) by 3.85 percent. This is a 26.47 percent increase over losses of $(0.34) per share

Benzinga · 11/08/2019 16:13

Adverum Biotechnologies (NASDAQ:ADVM) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.26) by 3.85 percent. This is a 26.47 percent increase over losses of $(0.34) per share from the same period last year. The company reported quarterly sales of $250 thousand which beat the analyst consensus estimate of $180 thousand by 38.89 percent. This is a 69.99 percent decrease over sales of $833 thousand the same period last year.